Genflow Biosciences plc (GENFF)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of $12.77 million as of February 12, 2026. Its market cap has increased by 36.94% in one year.
Market Cap
12.77M
Enterprise Value
12.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 45.94M to 12.77M, a decrease of -72.19%. That is a compound annual growth rate of -26.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 12.79M | 4.12% |
| Dec 31, 2025 | 12.29M | 62.72% |
| Dec 31, 2024 | 7.55M | 42.24% |
| Dec 29, 2023 | 5.31M | -37.23% |
| Dec 30, 2022 | 8.46M | -81.59% |
| Jan 17, 2022 | 45.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zenith Capital | 20.77M |
| Provectus Biopharmaceuticals | 18.79M |
| Zeo ScientifiX | 18.66M |
| HOOKIPA Pharma | 13.63M |
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |